ISRG
68
-3
FLR
46
-2
EQIX
60
-3
MAT
39
-6
AXP
69
2
SBUX
32
-9
KO
44
-2
WBA
64
4
RSG
62
-2
ADSK
63
-5
HUM
33
2
AVB
57
-2
EW
53
-2
XRX
52
3
ORCL
52
-7
FTI
76
3
ROK
52
-2
VRSK
63
-3
HAS
32
-5
TROW
50
2
ISRG
68
-3
FLR
46
-2
EQIX
60
-3
MAT
39
-6
AXP
69
2
SBUX
32
-9
KO
44
-2
WBA
64
4
RSG
62
-2
ADSK
63
-5
HUM
33
2
AVB
57
-2
EW
53
-2
XRX
52
3
ORCL
52
-7
FTI
76
3
ROK
52
-2
VRSK
63
-3
HAS
32
-5
TROW
50
2
Financhill
Back

Avalo Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
31

AVTX
Avalo Therapeutics

Last Price:
9.30
Seasonality Move:
10.12%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.58
Seasonality Move:
-6.51%
Sell
31
Avalo Therapeutics (AVTX) is a Sell

Is Avalo Therapeutics a Buy, Sell or Hold?

  • The current Avalo Therapeutics [AVTX] share price is $9.23. The Score for AVTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • AVTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AVTX Stock Price Chart

What is Avalo Therapeutics's stock price today?

  • The Avalo Therapeutics share price today is $9.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVTX is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

AVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 36.43 Sell
Chaikin Money Flow: 87044 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.33 - 12.11) Sell
Bollinger Bands (100): (8.72 - 11.98) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.63 Sell
Chaikin Money Flow: 40319 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.57 - 0.71) Sell
Bollinger Bands (100): (0.4 - 0.86) Sell

AVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.76 Sell
20-day SMA: 10.12 Sell
50-day SMA: 11.17 Sell
200-day SMA: 10.89 Sell
8-day EMA: 9.62 Sell
20-day EMA: 10.22 Sell
50-day EMA: 10.69 Sell
200-day EMA: 37.33 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Buy
20-day SMA: 0.62 Sell
50-day SMA: 0.65 Sell
200-day SMA: 2 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.61 Sell
50-day EMA: 0.67 Sell
200-day EMA: 4.92 Sell

Avalo Therapeutics Earnings Growth & AVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Avalo Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):